Definition, Etiology, Risk Factors, and Clinical Symptoms of Shock
Shock is a life-threatening acute circulatory failure characterized by decreased tissue perfusion, leading to inadequate oxygen delivery and/or oxygen utilization to meet cellular metabolic demands, resulting in cellular dysoxia and organ dysfunction. 1
Definition
Shock represents a generalized form of acute circulatory failure where cells cannot adequately utilize oxygen, leading to cellular dysoxia and elevated blood lactate levels 1. This pathophysiological state results in organ dysfunction and carries mortality rates ranging from 20-50% 1.
A critical point: hypotension, while commonly present, is NOT required to define shock 1. This is a common pitfall—clinicians may miss early shock in patients with normal blood pressure who demonstrate other signs of hypoperfusion.
Etiology and Underlying Patterns
Shock manifests through four distinct hemodynamic patterns 1:
Three Low-Flow States:
- Hypovolemic shock: Decreased intravascular volume (hemorrhage, dehydration, fluid losses)
- Cardiogenic shock: Myocardial pump failure (myocardial infarction, heart failure, arrhythmias)
- Obstructive shock: Mechanical obstruction to circulation (pulmonary embolism, cardiac tamponade, tension pneumothorax)
One Hyperkinetic State:
- Distributive shock: Inappropriate vasodilation with maldistribution of blood flow (septic shock, anaphylaxis, neurogenic shock)
Important caveat: Shock frequently results from a combination of these processes rather than a single mechanism 1. For example, septic shock often involves both distributive and hypovolemic components.
Clinical Symptoms and Signs
Cardinal Features 1:
The typical presentation includes:
- Tachycardia
- Hypotension (though not mandatory for diagnosis)
- Signs of hypoperfusion affecting three readily accessible organ systems:
1. Skin Perfusion:
- Abnormal capillary refill time (prolonged)
- Cold, clammy skin
- Mottling
- Altered skin temperature
2. Renal Perfusion:
- Decreased urine output (oliguria)
3. Cerebral Perfusion:
- Altered mental status
- Confusion, agitation, or decreased consciousness
Laboratory Markers 1:
Lactate levels are typically elevated (>2 mmol/L) in shock states and serve as a key biomarker of tissue hypoperfusion 1. Serial lactate measurements should be performed to guide monitoring and assess response to therapy.
Critical Assessment Principles
Never rely on a single variable for diagnosis or management of shock 1. This is an ungraded best practice statement with strong agreement. The diagnosis requires integration of:
- Hemodynamic parameters (blood pressure, heart rate)
- Clinical perfusion assessment (skin, urine output, mental status)
- Laboratory markers (lactate, venous oxygen saturation)
- Serial assessments to track evolution
Monitoring Recommendations:
For patients with shock, serial assessment should include 1:
- Blood lactate measurements (Level 1 recommendation)
- Capillary refill time assessment, complemented by skin temperature and mottling evaluation
- Central venous oxygen saturation (if central venous catheter present)
- Veno-arterial CO2 gradient (if both central and arterial access available)
Risk Factors
While the guidelines focus primarily on definition and clinical features rather than specific risk factors, the underlying etiologies themselves represent the primary risk factors:
- Conditions causing volume loss (trauma, gastrointestinal bleeding, burns)
- Cardiac disease (acute coronary syndromes, decompensated heart failure)
- Infection leading to sepsis
- Conditions causing vascular obstruction
- Immunocompromised states
- Advanced age and comorbidities (associated with higher mortality)
The key to reducing morbidity and mortality is timely recognition through comprehensive evaluation of multiple clinical and laboratory parameters, followed by rapid identification of the underlying mechanism(s) to guide appropriate intervention 1.